Company Update (NYSE:STJ): New Data Presented at EuroPCR 2015 Adds to the Growing Body of Clinical Evidence Supporting St. Jude Medical Fractional Flow Reserve Technology

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced new results from two clinical studies further supporting the use of St. Jude Medical fractional flow reserve technology . . . → Read More: Company Update (NYSE:STJ): New Data Presented at EuroPCR 2015 Adds to the Growing Body of Clinical Evidence Supporting St. Jude Medical Fractional Flow Reserve Technology Similar Articles: Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical to Present at Bank of America Merrill Lynch 2015 Health Care Conference Stock Update (NYSE:STJ): St. Jude Medical Completes Acquisition of Spinal Modulation, Inc. Company Update (NYSE:STJ): St. Jude Medical Reports First Quarter 2015 Results